186 related articles for article (PubMed ID: 16691090)
1. Treatment of chronic low back pain with successive injections of botulinum toxin a over 6 months: a prospective trial of 60 patients.
Ney JP; Difazio M; Sichani A; Monacci W; Foster L; Jabbari B
Clin J Pain; 2006 May; 22(4):363-9. PubMed ID: 16691090
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study.
Jabbari B; Ney J; Sichani A; Monacci W; Foster L; Difazio M
Pain Med; 2006; 7(3):260-4. PubMed ID: 16712627
[TBL] [Abstract][Full Text] [Related]
3. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K
Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.
Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G
Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study.
Wittekindt C; Liu WC; Preuss SF; Guntinas-Lichius O
Laryngoscope; 2006 Jul; 116(7):1168-71. PubMed ID: 16826054
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
[TBL] [Abstract][Full Text] [Related]
8. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.
Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E
J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941
[TBL] [Abstract][Full Text] [Related]
9. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of botulinum toxin A in treatment of tinnitus.
Stidham KR; Solomon PH; Roberson JB
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):883-9. PubMed ID: 15944559
[TBL] [Abstract][Full Text] [Related]
11. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection.
Vasan CW; Liu WC; Klussmann JP; Guntinas-Lichius O
Head Neck; 2004 Jan; 26(1):39-45. PubMed ID: 14724905
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
Lew HL; Lee EH; Castaneda A; Klima R; Date E
Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
[TBL] [Abstract][Full Text] [Related]
14. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
Jeffery S; Fynes M; Lee F; Wang K; Williams L; Morley R
BJU Int; 2007 Dec; 100(6):1302-6. PubMed ID: 17979928
[TBL] [Abstract][Full Text] [Related]
16. Fluoroscopically guided caudal epidural steroid injections in degenerative lumbar spine stenosis.
Botwin K; Brown LA; Fishman M; Rao S
Pain Physician; 2007 Jul; 10(4):547-58. PubMed ID: 17660853
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
Schulte-Mattler WJ; Krack P;
Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
[TBL] [Abstract][Full Text] [Related]
18. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial variables in patients with (sub)acute low back pain: an inception cohort in primary care physical therapy in The Netherlands.
Heneweer H; Aufdemkampe G; van Tulder MW; Kiers H; Stappaerts KH; Vanhees L
Spine (Phila Pa 1976); 2007 Mar; 32(5):586-92. PubMed ID: 17334295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
